alexa
Reach Us +441467840001
Editor - Kalyan Nagulapalli Venkata | University of Southern Cal | 8850
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Kalyan Nagulapalli Venkata

Kalyan Nagulapalli Venkata
Kalyan Nagulapalli Venkata
Research Associate
Loker Hydrocarbon Institute
University of Southern California
USA
University of Southern California

Biography

Dr. Kalyan Nagulapalli Venkata graduated with Bachelor of Pharmacy degree from Osmania University, India. He came to US in 2001 to earn MS in Chemistry from Illinois State University, Normal, IL and later completed his Ph.D from University of Southern California under the guidance of Professor Nicos Petasis. After graduation, he joined AMRI, Albany, NY in a senior research scientist role in the medicinal chemistry department, where he was involved in the development of late stage cardiovascular drugs for treatment of stroke and cardiac arrythmias. Currently he works as Postdoctoral research associate at University of Southern California. He is also involved in the development of novel methods for the synthesis of heterocycles such as Indole and Benzodiazepine like molecules.

Research Interest

His primary research focus involves the synthesis of potent anti-inflammatory, anti-cancer biomolecules (lipoxins, resolvins) and synthetic anti-cancer agents.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Top